NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

The odds of L failing are very low, IMO. Will the trial be stat sig? That remains to be seen. But there will be multiple pathways forward to prevent any potential failing to get this treatment into the hands of patients, should the trial not be stat sig. And this will only be know after they unblind the data. The company can only make educated guesses at this time as to what the data might ultimately demonstrate.

If DCVax-L fails odds are better than even Direct is the proverbial bill of goods too